Literature DB >> 34183373

Deletion of the Feeding-Induced Hepatokine TSK Ameliorates the Melanocortin Obesity Syndrome.

Qiuyu Wang1, Peng Zhang1, Isin Cakir2, Lin Mi1, Roger D Cone2, Jiandie D Lin3.   

Abstract

Work in recent decades has established that metabolic hormones released by endocrine cells and diverse other cell types serve to regulate nutrient intake and energy homeostasis. Tsukushi (TSK) is a leucine-rich repeat-containing protein secreted primarily by the liver that exerts an inhibitory effect on brown fat sympathetic innervation and thermogenesis. Despite this, physiological regulation of TSK and the mechanisms underlying its effects on energy balance remain poorly understood. Here we show that hepatic expression and plasma concentrations of TSK are induced by feeding and regulated by melanocortin-4 receptor (MC4R) signaling. We generated TSK and MC4R-double-knockout mice to elucidate the nature of cross talk between TSK and the central regulatory circuit of energy balance. Remarkably, TSK inactivation restores energy balance, ameliorates hyperphagia, and improves metabolic health in MC4R-deficient mice. TSK ablation enhances thermogenic gene expression in brown fat, dampens obesity-association inflammation in the liver and adipose tissue, and protects MC4R-null mice from diet-induced nonalcoholic steatohepatitis. At the cellular level, TSK deficiency augments feeding-induced c-Fos expression in the paraventricular nucleus of the hypothalamus. These results illustrate physiological cross talk between TSK and the central regulatory circuit in maintaining energy balance and metabolic homeostasis.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34183373      PMCID: PMC8576423          DOI: 10.2337/db21-0161

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.337


  36 in total

Review 1.  Understanding the Physiology of FGF21.

Authors:  Ffolliott Martin Fisher; Eleftheria Maratos-Flier
Journal:  Annu Rev Physiol       Date:  2015-11-19       Impact factor: 19.318

2.  Selective antagonist for the melanocortin 4 receptor (HS014) increases food intake in free-feeding rats.

Authors:  A Kask; L Rägo; F Mutulis; R Pähkla; J E Wikberg; H B Schiöth
Journal:  Biochem Biophys Res Commun       Date:  1998-04-07       Impact factor: 3.575

3.  Importance of melanocortin signaling in refeeding-induced neuronal activation and satiety.

Authors:  Praful S Singru; Edith Sánchez; Csaba Fekete; Ronald M Lechan
Journal:  Endocrinology       Date:  2006-10-26       Impact factor: 4.736

4.  Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue.

Authors:  Adriana Voss-Andreae; Jonathan G Murphy; Kate L J Ellacott; Ronald C Stuart; Eduardo A Nillni; Roger D Cone; Wei Fan
Journal:  Endocrinology       Date:  2006-12-28       Impact factor: 4.736

5.  Melanocortin 4 receptor-deficient mice as a novel mouse model of nonalcoholic steatohepatitis.

Authors:  Michiko Itoh; Takayoshi Suganami; Nobutaka Nakagawa; Miyako Tanaka; Yukio Yamamoto; Yasutomi Kamei; Shuji Terai; Isao Sakaida; Yoshihiro Ogawa
Journal:  Am J Pathol       Date:  2011-09-07       Impact factor: 4.307

Review 6.  60 YEARS OF POMC: Regulation of feeding and energy homeostasis by α-MSH.

Authors:  Erica J P Anderson; Isin Çakir; Sheridan J Carrington; Roger D Cone; Masoud Ghamari-Langroudi; Taneisha Gillyard; Luis E Gimenez; Michael J Litt
Journal:  J Mol Endocrinol       Date:  2016-03-03       Impact factor: 5.098

7.  The hepatokine Tsukushi gates energy expenditure via brown fat sympathetic innervation.

Authors:  Qiuyu Wang; Vishal P Sharma; Hong Shen; Yuanyuan Xiao; Qi Zhu; Xuelian Xiong; Liang Guo; Lin Jiang; Kunimasa Ohta; Siming Li; Haifei Shi; Liangyou Rui; Jiandie D Lin
Journal:  Nat Metab       Date:  2019-01-14

8.  The Hepatokine TSK does not affect brown fat thermogenic capacity, body weight gain, and glucose homeostasis.

Authors:  Mathilde Mouchiroud; Étienne Camiré; Manal Aldow; Alexandre Caron; Éric Jubinville; Laurie Turcotte; Inés Kaci; Marie-Josée Beaulieu; Christian Roy; Sébastien M Labbé; Thibault V Varin; Yves Gélinas; Jennifer Lamothe; Jocelyn Trottier; Patricia L Mitchell; Frédéric Guénard; William T Festuccia; Philippe Joubert; Christopher F Rose; Constantine J Karvellas; Olivier Barbier; Mathieu C Morissette; André Marette; Mathieu Laplante
Journal:  Mol Metab       Date:  2019-10-04       Impact factor: 7.422

9.  Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques.

Authors:  Paul Kievit; Heather Halem; Daniel L Marks; Jesse Z Dong; Maria M Glavas; Puspha Sinnayah; Lindsay Pranger; Michael A Cowley; Kevin L Grove; Michael D Culler
Journal:  Diabetes       Date:  2012-10-09       Impact factor: 9.461

10.  Mapping the molecular signatures of diet-induced NASH and its regulation by the hepatokine Tsukushi.

Authors:  Xuelian Xiong; Qiuyu Wang; Shuai Wang; Jinglong Zhang; Tongyu Liu; Liang Guo; Yonghao Yu; Jiandie D Lin
Journal:  Mol Metab       Date:  2018-12-15       Impact factor: 7.422

View more
  3 in total

1.  The hepatokine TSK maintains myofiber integrity and exercise endurance and contributes to muscle regeneration.

Authors:  Qiuyu Wang; Xiaoxue Qiu; Tongyu Liu; Cheehoon Ahn; Jeffrey F Horowitz; Jiandie D Lin
Journal:  JCI Insight       Date:  2022-02-22

Review 2.  The evolving view of thermogenic fat and its implications in cancer and metabolic diseases.

Authors:  Xinpeng Yin; Yuan Chen; Rexiati Ruze; Ruiyuan Xu; Jianlu Song; Chengcheng Wang; Qiang Xu
Journal:  Signal Transduct Target Ther       Date:  2022-09-16

3.  Plasma Tsukushi Concentration Is Associated with High Levels of Insulin and FGF21 and Low Level of Total Cholesterol in a General Population without Medication.

Authors:  Masato Furuhashi; Yukimura Higashiura; Akiko Sakai; Masayuki Koyama; Marenao Tanaka; Shigeyuki Saitoh; Kazuaki Shimamoto; Hirofumi Ohnishi
Journal:  Metabolites       Date:  2022-03-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.